Jerome Stevens Pharmaceuticals

Executive Summary

Jerome Stevens Pharmaceuticals is a privately held generic drug manufacturer based in Bohemia, New York, best known for its lead product UNITHROID® (levothyroxine sodium), which was the first FDA-approved levothyroxine sodium product and is established as the reference drug for hypothyroidism. Founded in 1990, the company operates with a focused portfolio, primarily serving the thyroid hormone replacement therapy market. Despite limited public information, its approved status and long-standing presence suggest stable operations. However, as a single-product company, it faces risks from generic competition and pricing pressure. Future growth may depend on expanding its product line or securing new FDA approvals.

Upcoming Catalysts (preview)

• TBDPotential launch of additional generic products through internal development or partnerships30% success
• TBDFDA approval for label expansion or new indication of UNITHROID20% success